Latest News and Press Releases

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug...

Survey Finds After Three Quarters of Bullish Momentum, Investor Sentiment Predictably Withdraws amid Iran War Fallout

U.S. Government has certified NOVONIX's Riverside project in connection with the US$103 million in tax credits.

Tagsley GPS Tracking Card claims evaluated: 2026 Apple Find My wallet tracker battery, Bluetooth range, and official website details verified.

Western Pacific Trust Company announces Change of Auditor

LUBBOCK, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Aligned Data Centers (“Aligned”), a leading developer and operator of ultra-efficient data centers for hyperscale, cloud, and AI workloads, today...

Pure Sunfarms brand is first to introduce THC ranges on top-selling flower in British Columbia Pilot program builds on the Company’s recent THC variability research, translating science into a more...

WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply...

EMPAVELIMD (pegcétacoplan) est le premier traitement autorisé dans le traitement des patients adultes et pédiatriques de 12 ans et plus atteints de glomérulopathie à dépôts de C3 (GC3) ou de...

EMPAVELI® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced...